Oyanagi, Takeshi
Kawanabe, Shin http://orcid.org/0000-0003-4302-6262
Tsukiyama, Hidekazu
Nishine, Ami
Nakamura, Yuta
Nakagawa, Tomoko
Kanou, Mayuko
Kubota, Juri
Tsunemi, Shingo
Yokota, Kenichi
Sone, Masakatsu
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Effects of Imeglimin on Muscle Strength in Patients with Type 2 Diabetes: A Prospective Cohort Study
https://doi.org/10.1007/s13300-024-01639-x
Article History
Received: 16 June 2024
Accepted: 6 August 2024
First Online: 9 September 2024
Declarations
:
: The authors (Takeshi Oyanagi, Shin Kawanabe, Hidekazu Tsukiyama, Ami Nishine, Yuta Nakamura, Tomoko Nakagawa, Mayuko Kanou, Juri Kubota, Shingo Tsunemi, Kenichi Yokota and Masakatsu Sone) declare no conflict of interest.
: Approval of the research protocol: The protocol for this research project has been approved by a suitably constituted Ethics Committee of the institution, and it conforms to the provisions of the Declaration of Helsinki: Clinical Research Ethics Committee of the St. Marianna University School of Medicine, Approval No. 5603. Approval date of Registry and the Registration No. of the study/trial: This study was registered with the UMIN Clinical Trials Registry (UMIN-CTR) on June 20, 2024, under the registration number UMIN000054715. The participants received a detailed explanation regarding the study’s aims and objectives, and written informed consent was obtained from all participants.